ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...
The Certificates, requested by HYTN in February, are important for drug registrations in jurisdictions where they apply. They also provide assurance in regions with limited regulatory frameworks, ...
The drug industry is lobbying for potential tariffs to be implemented gradually instead of immediately being imposed at a 25% ...
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s ...
Massive announcement today: Trump announces 10% tariff on ALL imports - regardless of where from - plus massive new tariffs on dozens if not hundreds of additional countries They include: China - 34% ...
LONDON/COPENHAGEN (Reuters) -Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled ...
Export manufacturing and free trade helped transform China and other Asian countries into economic powerhouses. U.S.
Growth in Specialty and Orphan Drug Approvals: The FDA’s focus on specialty medications and orphan drugs continues to expand, with 71% of recent submissions being for specialty medications and 34% for ...
The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth, Cigna and ...
6hon MSN
U.S. Rep. Mike Kelly, a Republican from Butler County who owned a group of auto dealerships, was among those skeptical of ...
StockStory.org on MSN19h
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The PackThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results